Strategic partnerships Position Samsara Sciences as a specialized provider of primary human liver cells with comprehensive donor pathology data, offering bundled access to cells, matched tissue sections, FFPE slides, and companion data to accelerate pharma and academic research partnerships.

Clinical-grade data Highlight the board-certified pathologist review, NAFLD scoring, and detailed phenotype/gene expression profiles to support regulatory-grade study designs, enabling customers to interpret results with confidence and reducing exploratory risk.

Donor diversity Emphasize access to cells from both healthy and NAFLD donors across hepatocytes, stellates, Kupffer cells, and liver endothelial cells to cater to preclinical NAFLD/NASH programs and mechanistic liver disease studies.

Integrated offerings Leverage the ability to sell matched donor tissue, nucleic acids, and profile data alongside cells to create end-to-end research kits, increasing average order value and customer stickiness.

Strategic value Frame the company as a niche, high-credibility supplier within Organovo’s ecosystem, with potential upsell opportunities to collaborators and funders in regenerative medicine, organ/tissue modeling, and translational liver research partnerships.